EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (4 days ago)
Join us for our first 2021 #webinar with #SaferWorldbyDesign partner @wepredic Prediction of the cholestatic pote… https://t.co/rXfvcHEfTT
Edelweiss Connect (2 months ago)
Join us for the upcoming #SaferWorldbyDesign webinar Validated HepaRG™ mechanistic methods as a tool for dynamic a… https://t.co/jQJSMIwWB3
Edelweiss Connect (3 months ago)
RT @barryhardy: Communicating cell culturing protocol knowledge - initial #HepaRG examples available on #saferworldbydesign https://t.co/O…
Edelweiss Connect (3 months ago)
RT @oak2: You may wonder: what does it mean, going digital, for a cell product like #HepaRG. This encompasses a set of various services suc…
Edelweiss Connect (4 months ago)
RT @skillsmatter: Next week at the #fsharpX 2020 virtual conference: See how #TypeProviders are built. @Odytrice will be sharing an exam…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA